nomegestrol acetate has been researched along with Hyperlipoproteinemia Type II in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chevallier, T; Jamin, C; Leber, C; Micheletti, MC; Zartarian, M | 1 |
1 other study(ies) available for nomegestrol acetate and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
[Biological and clinical safety of nomegestrol acetate administered alone then associated in inverse sequence with transdermal 17 beta estradiol, in women at risk of dyslipoproteinemia type IIa].
Topics: Administration, Cutaneous; Adolescent; Adult; Blood Pressure; Contraceptives, Oral, Sequential; Estradiol; Female; Humans; Hyperlipoproteinemia Type II; Megestrol; Middle Aged; Norpregnadienes; Progesterone Congeners | 1998 |